tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal has been researched along with Coronary Thrombosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gesellchen, PD; Growe, VG; Jackson, CV; Shuman, RT; Wilson, HC | 1 |
1 other study(ies) available for tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal and Coronary Thrombosis
| Article | Year |
|---|---|
Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis.
Topics: Animals; Antithrombins; Bleeding Time; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Hemodynamics; Heparin; Oligopeptides; Tissue Plasminogen Activator | 1993 |